Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2015
Reporting Period: Fiscal quarter ended September 30, 2015 (Third Quarter 2015).
This filing serves to announce the Company's financial results for the third quarter of 2015 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended September 30, 2015.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release titled "Capricor Therapeutics Reports Third Quarter 2015 Business & Financial Highlights" for detailed commentary.
Legal Disclaimer: The information furnished under Item 2.02 and Exhibit 99.1 is not deemed filed for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for specific revenue, net loss, and cash position figures for Q3 2015.
- Verify the Company's cash runway and burn rate as disclosed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the business highlights.
- Confirm if the press release includes updated financial guidance or outlook for the remainder of 2015.